FDA anti-bioterrorism
Executive Summary
Division of Special Pathogens & Immunologic Drug Products Medical Officer Andrea Meyerhoff, MD, becomes director of anti-bioterrorism program July 16. The program is in the Office of Science Coordination & Communication